{"id":"W1750189415","doi":"10.1200/jco.2005.23.16_suppl.756","title":"Subgroup analysis of a phase III trial of doxorubicin vs doxorubicin plus tesmilifene in advanced breast cancer (ABC): Tesmilifene survival benefit focused on patients with more aggressive disease","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Doxorubicin; Internal medicine; Chemotherapy; Subgroup analysis; Oncology; Breast cancer; Proportional hazards model; Survival analysis; Cancer; Gastroenterology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004244766,0.001130993,0.002742295,0.0005214754,0.0003140587,0.00103222,0.000608641,0.001116689,0.003808807],"category_scores_gemma":[0.004957642,0.0003250895,0.007124791,0.0004617594,0.0003596874,0.0004957278,0.0005547244,0.001610971,0.0004048113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000825643,"about_ca_system_score_gemma":0.000932545,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009712508,"about_ca_topic_score_gemma":0.003593876,"domain_scores_codex":[0.9978881,0.00121673,0.0002776403,0.000286058,0.0001452681,0.0001861912],"domain_scores_gemma":[0.9980978,0.0009653242,0.0002777474,0.0003303227,0.00009445402,0.0002343793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.9012277,0.001377101,0.02138851,0.001021354,0.03740507,0.0002843845,0.0001714936,0.001497228,0.009792822,0.000250022,0.002346152,0.02323826],"study_design_scores_gemma":[0.5862719,0.1122425,0.146137,0.0003025354,0.1287398,0.0006834574,0.0004553303,0.007383263,0.007057832,0.002656896,0.00790209,0.0001673069],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895207,0.005284632,0.0006938684,0.0005542643,0.0002555649,0.0007665021,0.001919119,0.00003545804,0.0009699914],"genre_scores_gemma":[0.9953858,0.0005552432,0.0005189046,0.0006391191,0.0001491091,0.0005618898,0.001458564,0.0000152818,0.0007160453],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004244766,"threshold_uncertainty_score":0.02244872,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05199588958467272,"score_gpt":0.4596695678042299,"score_spread":0.4076736782195571,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}